'The use of recombinant DNA technology can only benefit humans'

Authors Avatar

Kelly Heritage

‘The use of recombinant DNA technology can only benefit humans’

Recombinant DNA technology is the combining of the DNA from one organism with DNA from another organism. There are many steps in creating recombinant DNA. It begins with the isolation of a gene of interest. This gene is cut using restriction enzyme which will cut the gene in a particular place. A vector is taken and cut open with the same restriction enzyme as the gene was cut with. A vector is a piece of DNA that is capable of growth. Common vectors are of that of a bacterial plasmid. Once vector and gene have been cut they are joined at their sticky ends by using DNA ligase.

The viruses and transgenic bacteria used as vectors in the recombinant DNA technology could undergo mutilation which could produce a new pathogen which we won’t be able to control.

        Recombinant DNA technology can have many benefits to humans; one of these benefits is the process of gene therapy. “Gene therapy is a way of treating disease by either replacing damaged or abnormal genes with normal ones or by providing new genetic instructions to help fight disease” (BBC News – Question and answer)

        In gene therapy instead of using drugs to treat and control the disease the doctor can introduce healthy copies of the damaged or missing gene into the patient’s cells. These therapies have been suggested to treat a number of patients with a range of conditions and diseases.

        Gene therapy can be used to control the symptoms of Parkinson’s. Parkinson’s affects how the brain controls movement. The “region in the centre subthalamic nucleus (STN) of the brain is over active in Parkinson’s patients”. (BBC News – 10th October 2002) Scientists propose that a GAD gene could cause the release of a small molecule, GABA, which is released by nerve cells to inhibit or dampen brain activity. Scientists would deliver the gene directly to over active cells by inserting the gene into a modified virus. This would reset active cells and brain activity would return to normal.

Join now!

        Severe combined immunodeficiency (SCID) more commonly known as “Baby in a bubble” syndrome has also be successful with gene therapy. SCID “is caused by a single mutated gene, and this means that they have to live in sterile conditions or risk picking up a life-threatening infection.” (BBC News – 3rd April 2002) This gene therapy adds in a correctly – functioning version of the faulty gene. This would generate further cells to pass into the blood stream and protect from infection.

        Gene therapy has also looked in to cures for “genetic disorders such as cystic fibrosis, sickle-cell anaemia and cancer” (Robert ...

This is a preview of the whole essay